STABLECOIN DEVELOPMENT CORP: Low P/E, High Upside in Topical Anti‑Infective Pharma
STABLECOIN DEVELOPMENT CORP (STDC) is a small‑cap pharma focused on topical anti‑infectives, boasting a low P/E and high upside potential if Phase 2 trials succeed and strategic partnerships materialize.
3 minutes to read

